Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Chine-Yu Lin · SciRah

Researcher profile · Semantic Scholar

Chine-Yu Lin

Share profile

Chine-Yu Lin — researcher profile on SciRah

h-index: 16
Works: 22
Citations: 1,828

Most-cited papers

Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients
R. Yauch, T. Januario, D. Eberhard, G. Cavet +10 more
2005Clinical Cancer Research538 citations
Semantic Scholar
A Pilot Trial of Vitaxin, A Humanized Anti-Vitronectin Receptor (anti α v β 3) Antibody in Patients with Metastatic Cancer
J. Posey, M. Khazaeli, A. Delgrosso, M. Saleh +3 more
2001215 citations
Semantic Scholar
Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.
Yasuyoshi Ueki, Chine-Yu Lin, M. Senoo, Takeshi Ebihara +7 more
2007Cell191 citations Open access
Semantic Scholar
ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancer.
B. Johnson, F. Kabbinavar, L. Fehrenbacher, J. Hainsworth +11 more
2013Journal of Clinical Oncology176 citations
Semantic Scholar
Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of 18F-FDG PET and extended-field multi-detector row CT
S. Ng, Sheng-Chieh Chan, C. Liao, J. T. Chang +6 more
2008Neuroradiology91 citations
Semantic Scholar
Intraperitoneal Radioimmunochemotherapy of Ovarian Cancer: A Phase I Study
R. Meredith, R. Alvarez, E. Partridge, M. B. Khazaeli +7 more
2001Cancer Biotherapy and Radiopharmaceuticals89 citations
Semantic Scholar
Comprehensive imaging of residual/recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT
S. Ng, Sheng-Chieh Chan, T. Yen, C. Liao +6 more
2010European Radiology86 citations
Semantic Scholar
Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.
S. Makhija, L. Amler, D. Glenn, F. Ueland +10 more
2010Journal of Clinical Oncology82 citations Open access
Semantic Scholar
End of Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.
A. Khanani, D. Callanan, R. Dreyer, San-Ni Chen +8 more
2020Ophthalmology Retina77 citations Open access
Semantic Scholar
Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin‐resistant nasopharyngeal carcinoma
Chuan-Cheng Wang, Jang-Yang Chang, Tsang W. Liu, Chine-Yu Lin +2 more
2006Head and Neck63 citations
Semantic Scholar
Targeted radiotherapy with [90Y]‐SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector
Buck E. Rogers, Kurt R. Zinn, Chine-Yu Lin, T. Chaudhuri +1 more
2002Cancer45 citations Open access
Semantic Scholar
PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma
S. Ng, Sheng-Chieh Chan, T. Yen, C. Liao +6 more
2011European Journal of Nuclear Medicine and Molecular Imaging41 citations
Semantic Scholar
Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy
R. Hong, Chine-Yu Lin, Lai-Lei Ting, Jenq-Yuh Ko +1 more
2004Cancer40 citations
Semantic Scholar
The change in circulating tumor cells before and during concurrent chemoradiotherapy is associated with survival in patients with locally advanced head and neck cancer
Hung-Ming Wang, Min-Hsien Wu, Pei-Hung Chang, Hung-Chi Lin +7 more
2019Head and Neck34 citations
Semantic Scholar
Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer.
M. Danese, C. Reyes, K. Northridge, D. Lubeck +2 more
2008Clinical Therapeutics27 citations
Semantic Scholar
Results from a phase II randomized, placebo-controlled, double-blind trial suggest improved PFS with the addition of pertuzumab to gemcitabine in patients with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer
S. Makhija, D. Glenn, F. Ueland, M. Gold +6 more
200723 citations
Semantic Scholar
Epithelial versusMesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients
R. Yauch, T. Januario, D. Eberhard, G. Cavet +10 more
20056 citations
Semantic Scholar
Affecting quality of life in ovarian cancer: encouraging results from a randomized phase II trial of gemcitabine ± pertuzumab in women with platinum-resistant disease
D. Lalla, V. Paton, Chine-Yu Lin, D. Dizon
20084 citations
Semantic Scholar
Predicting an inhibitor response to a dimerization inhibitor based her HER3 expression under
L. Almer, M. Birkner, Chine-Yu Lin, J. Moecks +1 more
20090 citations
Semantic Scholar
Prediction of response to a HER dimeriseringsinhibitor from low HER3 expression
L. Amler, M. Birkner, Chine-Yu Lin, J. Moecks +1 more
20080 citations
Semantic Scholar
Prediction of the response to an HER dimerization inhibitor based on low HER3 expression
L. Amler, M. Birkner, Chine-Yu Lin, J. Moecks +1 more
20080 citations
Semantic Scholar
5002 ORAL Results from a Phase II randomized, placebo-controlled, double-blind trial suggest improved PFS with the addition of pertuzumab to gemcitabine in patients with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer
S. Makhija, D. Glenn, F. Ueland, D. Dizon +6 more
20070 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Amler×6
Invite
L. Amler — researcher profile on SciRah
A. Strauss×5
Invite
A. Strauss — researcher profile on SciRah
Hung-Ming Wang×4
Invite
Hung-Ming Wang — researcher profile on SciRah
D. Dizon×4
Invite
D. Dizon — researcher profile on SciRah

×4

Invite

V. Paton — researcher profile on SciRah

Invite

M. Birkner — researcher profile on SciRah

Invite

T. Januario — researcher profile on SciRah

Invite

S. Ng — researcher profile on SciRah

Sheng-Chieh Chan×3

Invite

Sheng-Chieh Chan — researcher profile on SciRah

Invite

C. Liao — researcher profile on SciRah

Invite

S. Ko — researcher profile on SciRah

Invite

T. Yen — researcher profile on SciRah